+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 38Years - 42Years
FEMALE
ID06154083

Impact of Different Doses of Follitropin-delta on Embryo Quality in Women Aged 38 to 42 Undergoing IVF with Genetic Testing

Led by Fundación Santiago Dexeus Font · Updated on 2026-09-08

110

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects of different intensities of ovarian stimulation on the number of healthy embryos in women of advanced age undergoing preimplantation genetic testing for aneuploidies PGT-A with a progestin-primed ovarian stimulation PPOS protocol. This randomized trial aims to determine if a milder stimulation approach is as effective as a more intense one in terms of embryo quality and developmental timing. Participants receive daily injections of Follitropin-delta Rekovelle starting on day 2 or 3 of their menstrual cycle. One study group receives 20 mcg per day, while the other receives 15 mcg per day. Throughout stimulation, scans and blood tests are performed on days 6, 8, and 10, and as needed until the trigger day, with doses remaining constant during the treatment period. During the study, participants are closely monitored with hormonal blood tests and ultrasound scans. Researchers will measure the number of chromosomally normal euploid embryos as the main outcome within about 20 to 30 days. Additional outcomes include hormone levels, stimulation length, embryo development timing, fertilization rates, and pregnancy rates. The entire study period lasts until the primary completion date, up to December 15, 2026.

CONDITIONS

Brief Title

INtensity of OVarian Stimualtion and Euploid Embryos

Research Team

N

Nikolaos P Polyzos, MD, PhD

I

Ignacio Rodríguez, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here